Novo Nordisk is ready for another round of the weight-loss-drug wars

Barron’s spoke with Dave Moore, executive vice president of U.S. operations, about Wegovy as a pill, rather than an injection.

from mint - science https://ift.tt/H5TJbul
https://ift.tt/Y0JpOAm